Replies to post #65990 on Biotech Values

[DewDiligence]

>Weight neutral, faster onset and offset leading to less hypoglycemic events, lower daily insulin usage.<

Can’t this be accomplished by tailoring a cocktail of insulin analogs?

[DewDiligence]

Type 2 Diabetics Treated with Lantus + Apidra Achieved Greater A1C Reduction Than Those Treated with Pre-mixed Insulin:

http://biz.yahoo.com/prnews/080910/3736999en_public.html

[genisi]

In addition to all the pitfalls mentioned, I see also a possible regulatory one as Biodel wants to file via 505(b)(2) and the FDA can be problematic like in the Omnitrope case.